Alaunos Therapeutics, Inc. (Nasdaq:TCRT)

Health Care/Life Sciences • Biotechnology

CIK 1107421

Company

Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. Its pipeline includes Library TCR-T cell and mblL-15 TCR-T cell Therapy. The company was founded in 2003 and is headquartered in Houston, TX.

Address
2617 Bissonnet Saint
Suite 225
Houston, Texas 77005

Employees
34

Stock Info

Close
$1.9000

Day Range
1.8607 - 2.0000

52 Week Range
0.6600 - 10.5000

Average volume
363.45K

Short Interest
1.66M (02/15/24)

% of Float Shorted
10.81%

Market Cap
$30.48M

Revenue
$2.92M

Net Income
-$37.73M

2020 Sales Growth
N/A

Rev. per Employee
$441.1760

P/E Ratio
N/A

EPS
-$2.3223

Yield
N/A

Dividend
N/A

Ex-Dividend Date
N/A

Key Executives

Board Of Directors

Chairman
Holger Weis CPA

Independent Director
Jaime Ward Vieser MBA

Independent Director
Robert Hofmeister PhD

Independent Director
Robert W Postma

SEC filings

Date	Form	Event
14 Nov, 2024	10-Q
14 Nov, 2024	SC 13G/A
10 Oct, 2024	8-K
16 Aug, 2024	4
16 Aug, 2024	4
14 Aug, 2024	10-Q
17 Jul, 2024	8-K/A
17 Jul, 2024	8-K/A
16 Jul, 2024	8-K
16 Jul, 2024	8-K
21 Jun, 2024	8-K
12 Jun, 2024	8-K
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
10 Jun, 2024	4
15 May, 2024	10-Q
26 Apr, 2024	ARS
26 Apr, 2024	DEFA14A
26 Apr, 2024	DEF 14A
15 Apr, 2024	PRE 14A
1 Apr, 2024	10-K
28 Feb, 2024	3
22 Feb, 2024	8-K
20 Feb, 2024	8-K
14 Feb, 2024	SC 13G/A
13 Feb, 2024	SC 13G/A
1 Feb, 2024	8-K
29 Jan, 2024	8-K
23 Jan, 2024	4
22 Jan, 2024	8-K	CEO Change
3 Jan, 2024	3
3 Jan, 2024	4
2 Jan, 2024	8-K
28 Dec, 2023	8-K	CEO Change
22 Dec, 2023	8-K
15 Nov, 2023	8-K
14 Nov, 2023	10-Q
14 Nov, 2023	8-K
28 Sep, 2023	8-K
5 Sep, 2023	4
1 Sep, 2023	144
14 Aug, 2023	10-Q
14 Aug, 2023	8-K
5 Jul, 2023	8-K
12 Jun, 2023	8-K
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
8 Jun, 2023	4
10 May, 2023	8-K
10 May, 2023	10-Q
25 Apr, 2023	DEFA14A
25 Apr, 2023	DEF 14A
19 Apr, 2023	4
19 Apr, 2023	3
14 Apr, 2023	PRE 14A
4 Apr, 2023	8-K
3 Apr, 2023	8-K
30 Mar, 2023	8-K
17 Mar, 2023	4
17 Mar, 2023	4
17 Mar, 2023	4
17 Mar, 2023	4
17 Mar, 2023	4
7 Mar, 2023	8-K
7 Mar, 2023	10-K
14 Feb, 2023	SC 13G/A
14 Feb, 2023	SC 13G/A
9 Feb, 2023	SC 13G/A
20 Jan, 2023	SC 13G/A
9 Jan, 2023	8-K
4 Jan, 2023	8-K
1 Dec, 2022	4
1 Dec, 2022	4
30 Nov, 2022	424B5
30 Nov, 2022	8-K
28 Nov, 2022	424B5
14 Nov, 2022	10-Q
14 Nov, 2022	8-K
7 Nov, 2022	8-K
30 Sep, 2022	8-K
21 Sep, 2022	8-K
19 Sep, 2022	4
19 Sep, 2022	4
19 Sep, 2022	4
19 Sep, 2022	4
7 Sep, 2022	424B5
7 Sep, 2022	EFFECT
6 Sep, 2022	8-K
2 Sep, 2022	CORRESP
1 Sep, 2022	4
31 Aug, 2022	S-3/A
24 Aug, 2022	8-K
19 Aug, 2022	UPLOAD
16 Aug, 2022	4
15 Aug, 2022	8-K
15 Aug, 2022	3
15 Aug, 2022	10-Q
12 Aug, 2022	S-3
4 Aug, 2022	8-K
13 Jul, 2022	8-K
8 Jul, 2022	SC 13G
27 Jun, 2022	8-K
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
24 Jun, 2022	4
17 Jun, 2022	8-K
24 May, 2022	8-K
16 May, 2022	10-Q
16 May, 2022	8-K
2 May, 2022	8-K
2 May, 2022	8-K
27 Apr, 2022	DEFA14A
27 Apr, 2022	DEF 14A
15 Apr, 2022	PRE 14A
8 Apr, 2022	3
1 Apr, 2022	4
1 Apr, 2022	4
30 Mar, 2022	S-8
30 Mar, 2022	10-K
30 Mar, 2022	8-K
18 Mar, 2022	8-K
17 Mar, 2022	8-K
14 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G/A
11 Feb, 2022	SC 13G
10 Feb, 2022	SC 13G/A
3 Feb, 2022	SC 13G/A
26 Jan, 2022	8-K
4 Jan, 2022	8-K
27 Dec, 2021	4
13 Dec, 2021	4
9 Dec, 2021	3
29 Nov, 2021	3
17 Nov, 2021	4
8 Nov, 2021	10-Q
5 Nov, 2021	8-K
12 Oct, 2021	SC 13G/A
4 Oct, 2021	4
1 Oct, 2021	8-K
27 Sep, 2021	8-K
3 Sep, 2021	4
3 Sep, 2021	4
3 Sep, 2021	4
3 Sep, 2021	4
31 Aug, 2021	3
31 Aug, 2021	4
30 Aug, 2021	8-K	CEO Change
13 Aug, 2021	10-Q
12 Aug, 2021	8-K
9 Aug, 2021	NT 10-Q
9 Aug, 2021	8-K
21 May, 2021	8-K
19 May, 2021	4
13 May, 2021	8-K
6 May, 2021	4
6 May, 2021	4
6 May, 2021	4
6 May, 2021	4
6 May, 2021	4
6 May, 2021	4
6 May, 2021	8-K
6 May, 2021	4
6 May, 2021	10-Q
9 Apr, 2021	8-K	CEO Change
7 Apr, 2021	DEFA14A
7 Apr, 2021	DEF 14A
31 Mar, 2021	3
25 Mar, 2021	8-K
25 Mar, 2021	PRE 14A
22 Mar, 2021	3
22 Mar, 2021	3
22 Mar, 2021	3
11 Mar, 2021	SEC STAFF
8 Mar, 2021	4
8 Mar, 2021	4
8 Mar, 2021	4
8 Mar, 2021	4
2 Mar, 2021	8-K	CEO Change
1 Mar, 2021	10-K
26 Feb, 2021	3
25 Feb, 2021	8-K
23 Feb, 2021	8-K
16 Feb, 2021	SC 13G/A
16 Feb, 2021	SC 13G/A
10 Feb, 2021	SC 13G/A
10 Feb, 2021	SEC STAFF
5 Feb, 2021	8-K
1 Feb, 2021	SC 13G/A
14 Jan, 2021	8-K
12 Jan, 2021	4
12 Jan, 2021	4
12 Jan, 2021	4
7 Jan, 2021	SC 13G
6 Jan, 2021	4
6 Jan, 2021	4
28 Oct, 2020	UPLOAD
27 Oct, 2020	UPLOAD
27 Oct, 2020	CORRESP
22 Oct, 2020	UPLOAD

Last update:2024-03-11 12:04:56.089639

Sign Up to Subscribe

Interested in special situations?

Join Tickerverse

customize event filters
create watchlists, bookmarks
get email notifications for the latest special situations
browse and analyze public companies, executives and SEC filings

Tickerverse is a great way to find investment opportunities in corporate actions.

By signing up you agree to our Terms of Service and Privacy Policy.